Overview

Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol

Status:
Completed

Trial end date:
2017-06-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to gain further experience with regard to the performance of the medical device WO2085 Moisturising Cream in comparison to a cream with 0.1% estriol.

Phase:

Phase 4

Details

Lead Sponsor:

Dr. August Wolff GmbH & Co. KG Arzneimittel

Collaborators:

Bremer Pharmacovigilance Service GmbH
GCP-Service International Ltd. & Co. KG
proDERM Institut für Angewandte Dermatologische Forschung GmbH